Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
October 27, 2026
A group of Massachusetts hospitals claim drugmaker Eli Lilly & Co. unlawfully holds hostage medication discounts meant to benefit low-income patients by demanding that hospitals hand over sensitive patient claims data or pay "exorbitant" inflated prices, according to a lawsuit filed Tuesday in Boston federal court.
-
October 27, 2026
A New Jersey federal judge has upheld the U.S. Patent and Trademark Office's refusal to extend the life of a pair of patents on a cancer drug, rejecting a challenge from the patent owner that claimed the loss of exclusivity would cost it more than $1 billion.
-
October 27, 2026
Law360 Healthcare Authority looks at a Novo Nordisk loss in its challenge to Eli Lilly's GLP-1 advertising, an Ohio verdict in wrongful death litigation over Johnson & Johnson's talc baby powder and other legal news from the past week.
-
October 27, 2026
A Texas bankruptcy judge Tuesday authorized pharmacy services provider Omnicare LLC to tweak its asset purchase agreement and transition services agreement and approved a third amendment to its $110 million debtor-in-possession financing agreement, finding the changes would not materially harm any party.
-
October 27, 2026
A group of generic-drug makers facing price-fixing claims brought by dozens of state attorneys general asked a Connecticut federal judge to bar or limit the use of terms like "Big Pharma" or "rising costs of pharmaceuticals and healthcare" in next year's trial.
See more Life Sciences news